Literature DB >> 2889600

By what means might beta blockers prolong life after acute myocardial infarction?

J D Fitzgerald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889600     DOI： 10.1093/oxfordjournals.eurheartj.a062371

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  Selective versus nonselective beta adrenoceptor antagonists in hypertension.

Authors:  L M Van Bortel; A J Ament
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 2.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 3.  The role of beta-receptor and calcium-entry-blocking agents in acute myocardial infarction in the thrombolytic era: can the results of thrombolytic reperfusion be enhanced?

Authors:  C J Lavie; J G Murphy; B J Gersh
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 4.  Do partial agonist beta-blockers have improved clinical utility?

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 5.  Prevention of sudden death by beta-blockade.

Authors:  N Rehnqvist
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.